Abstract:This paper reports the synthesis, analgesic activity, acute toxicity and histopathological (HP) assessment of four new compounds from oxazol-5(4H)-ones class that contain in their molecule a diarylsulfone moiety. The new 2-(4-(4-bromophenylsulfonyl)phenyl)-4-arylidene-oxazol-5(4H)-ones were obtained by reaction of 2-(4-(4-bromophenyl-sulfonyl)benzamido)acetic acid intermediate with aromatic aldehydes (benzaldehyde, 4-methoxy, 4-nitro or 4-bromobenzaldehyde), in acetic anhydride and in the presence of anhydrous sodium acetate. The new compounds have been characterized by spectral techniques, such as: Fourier-transform infrared spectroscopy (FT-IR), mass spectrometry (MS), proton nuclear magnetic resonance (1H-NMR) and by elemental analysis. The acute toxicity of the new oxazol-5(4H)-ones in mice was assessed through "acute toxic class" method, according to Organization for Economic Co-operation and Development (OECD) Guidelines. The HP assessment of some preserved organs collected from mice has been performed. The analgesic activity of all new synthesized compounds was carried out with two pharmacological tests: the writhing test and the hot plate test. In order to predict the binding affinities of the synthesized oxazol-5(4H)-ones derivatives against molecular targets involved in pain and inflammation, molecular docking simulations were performed. The results of the writhing test indicated that the most active compound was the oxazolone that contains in the molecule a methoxy group. The acute oral toxicity study revealed no lethal effect of new compounds. The HP assessment of the preserved organs collected from mice did not indicate any cytohistopathological aspects that can be linked to any inflammatory, neoplastic or cytotoxic process, demonstrating the low toxicity of new compounds.

Synthesis and Analgesic Activities Studies on Bispiperazinium (BPZ) Salts

Unique Spirocyclopiperazinium Salt. Part 4: Modification of Dispirocyclopiperazinium (DSPZ) Salts As Analgesics.

Synthesis and Structure–analgesic Activity Relationships of a Novel Series of Monospirocyclopiperazinium Salts (MSPZ)

Synthesis and Analgesic Activity of Dispirocyclopiperazinium Analogues

Unique Spirocyclopiperazinium Salt III: Further Investigation of Monospirocyclopiperazinium (MSPZ) Salts As Potential Analgesics.

Synthesis and Structure‐Activity Relationship of Di‐(3, 8‐diazabicyclo[3.2.1]octane) Diquaternary Ammonium Salts As Unique Analgesics

SYNTHESIS AND BIOLOGICAL ACTIVITIES OF 1,1′-DIACYL-4,4,4′,4′-TETRAALKYL DIPIPERAZINIUM DERIVATIVES

Synthesis and Analgesic Evaluation of a Series of Proline-Typed Spiro Cyclic Quaternary Ammoniums

Synthesis and Biological Activities of Dibenzyl Dipiperazine Diquaternary Ammonium Salts

Synthesis and pharmacological activities of 1,1-dialkyl-4 (3-bromopropionyl) piperazinium bromides

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Synthesis and Analgesic Activity of Secondary Amine Analogues of Pyridylmethylamine and Positional Isomeric Analogues of ABT-594

Unique Spirocyclopiperazinium Salt I: Synthesis and Structure—Activity Relationship of Spirocyclopiperazinium Salts As Analgesics.

Studies on Analgesic Effect of A New Compound of Piperaines

Optimization of bifunctional piperidinamide derivatives as σ1R Antagonists/MOR agonists for treating neuropathic pain

Design, synthesis, analgesic, antibacterial and docking studies of novel 8-piperazinylcaffeine carboxylate ionic liquids

Synthesis and Analgesic Activity of New Analogs of 1-[1-phenylcyclohexyl]piperidine with Modified Structures in its Tricyclic System

Synthesis and evaluation of novel 2-substituted-quinazolin-4(3H)-ones as potent analgesic and anti-inflammatory agents

Novel 1-Oxyl-2-substitutedphenyl-4,4,5,5-tetramethylimidazolines: Synthesis, Selectively Analgesic Action, and QSAR Analysis

New 2-(4-(4-bromophenylsulfonyl)phenyl)-4-arylidene-oxazol-5(4H)-ones: analgesic activity and histopathological assessment

Analgesic Activity of Methyl-6-Aryl-5-Aroyl-4-Methoxy-2-Oxo(Thioxo)-Hexahydropyrimidine-4-Carboxylates